Third Harmonic Bio Inc (NASDAQ: THRD) established initial surge of 4.97% at $13.93, before settling in for the price of $13.27 at the close. Taking a more long-term approach, THRD posted a 52-week range of $5.76-$16.94.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 0.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -49.20%. This publicly-traded company’s shares outstanding now amounts to $40.10 million, simultaneously with a float of $12.96 million. The organization now has a market capitalization sitting at $572.48 million. At the time of writing, stock’s 50-day Moving Average stood at $13.07, while the 200-day Moving Average is $11.83.
Third Harmonic Bio Inc (THRD) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Third Harmonic Bio Inc industry. Third Harmonic Bio Inc’s current insider ownership accounts for 68.46%, in contrast to 42.94% institutional ownership. According to the most recent insider trade that took place on Oct 29 ’24, this organization’s See Explanation of Responses sold 1,000,000 shares at the rate of 14.30, making the entire transaction reach 14,300,000 in total value, affecting insider ownership by 176,692. Preceding that transaction, on Oct 28 ’24, Company’s Chief Medical Officer sold 2,673 for 15.00, making the whole transaction’s value amount to 40,095. This particular insider is now the holder of 0 in total.
Third Harmonic Bio Inc (THRD) Earnings and Revenue Records
Third Harmonic Bio Inc’s EPS decrease for this current 12-month fiscal period is -49.20% and is forecasted to reach -1.45 in the upcoming year.
Third Harmonic Bio Inc (NASDAQ: THRD) Trading Performance Indicators
Let’s observe the current performance indicators for Third Harmonic Bio Inc (THRD). It’s Quick Ratio in the last reported quarter now stands at 41.13. The Stock has managed to achieve an average true range (ATR) of 1.04.
In the same vein, THRD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.82, a figure that is expected to reach -0.37 in the next quarter, and analysts are predicting that it will be -1.45 at the market close of one year from today.
Technical Analysis of Third Harmonic Bio Inc (THRD)
Now, what If we examine the latest scores posted by [Third Harmonic Bio Inc, THRD]. During the last 5-days, its volume was better the volume of 0.14 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 45.82% While, its Average True Range was 1.11.
Raw Stochastic average of Third Harmonic Bio Inc (THRD) in the period of the previous 100 days is set at 63.93%, which indicates a major fall in contrast to 67.67% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 94.87% that was higher than 61.48% volatility it exhibited in the past 100-days period.
